TY - JOUR
T1 - Abnormal Hepatic Transport of Indocyanine Green in Gilbert's Syndrome
AU - Martin, James F.
AU - Vierling, John M.
AU - Wolkoff, Allan W.
AU - Scharschmidt, Bruce F.
AU - Vergalla, John
AU - Waggoner, Jeanne G.
AU - Berk, Paul D.
PY - 1976
Y1 - 1976
N2 - The plasma fractional disappearance rate of indocyanine green (kICG min-1) and theabsolute hepatic ICG removal rate (V{in{scicg}}, mg per kg per min) were determined in 26 patients with Gilbert's syndrome (GS) and 19 normal control volunteers following intravenous administration of doses of 0.5, 2.0, 3.5, and 5.0 mg per kg of dye. The diagnosis of GS was based on studies of radiobilirubin kinetics in all cases and liver biopsy in 22 of 26 cases. The patients were further classified into 3 subgroups, based on patterns of sulfobromophthalein (BSP) kinetics, as follows: GS I (15 patients) had normal BSP metabolism; GS II (5 patients) had a defect in BSP metabolism beyond the stage of initial hepatic uptake; and GS III (6 patients) had a defect in the initial hepatic uptake of BSP (Gastroenterology 63:472-481,1972). Both kICG, and VICG were significantly reduced, compared to normal controls, in the GS III group with defective BSP uptake, but did not differ significantly from normal in the GS I and GS II groups. Michaelis-Menten analysis of the data indicated that V{in{scmax}} for ICG uptake in the GS III group (1.2 ± 0.6 mg per min per kg) was significantly reduced compared to the previously established normal value of 3.6 ± 0.6 mg per min per kg; (P < 0.01). For the total population of 26 patients with Gilbert's syndrome, there was a highly significant correlation (r = 0.77, P < 0.01) between k{in{scicg}} and λ21BSp, the fractional hepatic uptake rate for BSP. These studies confirm previous work indicating that patients with Gilbert's syndrome constitute a heterogeneous population with regard to defects in hepatic organic anion transport, some of the defects not being attributable to glucuronyl transferase deficiency. Future studies of Gilbert's syndrome must take into account the existence of these subgroups, since they may have different underlying pathogenetic mechanisms.
AB - The plasma fractional disappearance rate of indocyanine green (kICG min-1) and theabsolute hepatic ICG removal rate (V{in{scicg}}, mg per kg per min) were determined in 26 patients with Gilbert's syndrome (GS) and 19 normal control volunteers following intravenous administration of doses of 0.5, 2.0, 3.5, and 5.0 mg per kg of dye. The diagnosis of GS was based on studies of radiobilirubin kinetics in all cases and liver biopsy in 22 of 26 cases. The patients were further classified into 3 subgroups, based on patterns of sulfobromophthalein (BSP) kinetics, as follows: GS I (15 patients) had normal BSP metabolism; GS II (5 patients) had a defect in BSP metabolism beyond the stage of initial hepatic uptake; and GS III (6 patients) had a defect in the initial hepatic uptake of BSP (Gastroenterology 63:472-481,1972). Both kICG, and VICG were significantly reduced, compared to normal controls, in the GS III group with defective BSP uptake, but did not differ significantly from normal in the GS I and GS II groups. Michaelis-Menten analysis of the data indicated that V{in{scmax}} for ICG uptake in the GS III group (1.2 ± 0.6 mg per min per kg) was significantly reduced compared to the previously established normal value of 3.6 ± 0.6 mg per min per kg; (P < 0.01). For the total population of 26 patients with Gilbert's syndrome, there was a highly significant correlation (r = 0.77, P < 0.01) between k{in{scicg}} and λ21BSp, the fractional hepatic uptake rate for BSP. These studies confirm previous work indicating that patients with Gilbert's syndrome constitute a heterogeneous population with regard to defects in hepatic organic anion transport, some of the defects not being attributable to glucuronyl transferase deficiency. Future studies of Gilbert's syndrome must take into account the existence of these subgroups, since they may have different underlying pathogenetic mechanisms.
UR - http://www.scopus.com/inward/record.url?scp=0017277704&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0017277704&partnerID=8YFLogxK
U2 - 10.1016/S0016-5085(76)80151-5
DO - 10.1016/S0016-5085(76)80151-5
M3 - Article
C2 - 814028
AN - SCOPUS:0017277704
SN - 0016-5085
VL - 70
SP - 385
EP - 391
JO - Gastroenterology
JF - Gastroenterology
IS - 3
ER -